Reviral

Developer of antiviral compounds for RSV

placeLondon, England, United Kingdom calendar_todayFounded 2011 groups28 employees language reviral.co.uk

Registered entities

Innovation

11 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 209 times.

YearFilings
20161
20173
20183
20197
20206
20217
20229
20233
20242

Investor mix

8 investors on record; lead investors include New Leaf Venture Partners, Novo Holdings; 3 have since exited.

Investor typeCountShare
Venture capital450%
Private equity113%
Bank & private debt113%
Other / undisclosed225%
Coming soon